NNNN - Anbio Biotechnology News

Sectors

NNNN

Anbio Biotechnology

7.30

1 x 11.55

1 x 9.89

bid

ask

0.28

3.69%

1 @ 07:45 PM

7.38 +0.08 (1.10%)

Ytd	-75.72%
1y	-83.79%

7.08

day range

7.76

6.61

52 week range

51.33

Open	7.50	Prev Close	7.58	Low	7.08	High	7.76	Mkt Cap	320.41M
Vol	279.21K	Avg Vol	85.04K	EPS	0.14	P/E	52.14	Forward P/E	N/A
Beta	5.40	Short Ratio	1.79	Inst. Own	4.90%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	04-28	50-d Avg	10.59	200-d Avg	22.90	1yr Est	0.00

NNNN News

benzinga.com

Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

JOYY Inc (NASDAQ: JOYY) reported Q2 earnings below estimates, but beat revenue expectations. Shares

benzinga.com

H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks

H World Group (HTHT) beats earnings and raises sales guidance, shares jump 8.1%. Other big gainers i

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-mar

benzinga.com

Top 3 Health Care Stocks That May Rocket Higher In July

Health care sector oversold - buying opportunities in undervalued companies. RSI compares stock stre

benzinga.com

Top 3 Health Care Stocks That May Rocket Higher In July

Oversold health care stocks: EVMN, NNNN, NAUT. RSI <30 shows they may be undervalued. EVMN drop

benzinga.com

Top 3 Health Care Stocks You'll Regret Missing In Q2

Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold,

benzinga.com

12 Health Care Stocks Moving In Monday's Intraday Session

benzinga.com

Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio

Anbio Biotechnology reported strong 2025 results with sales of $8.65M. The company is diversifying a

defenseworld.net

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head-To-Head Contrast: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Financial Comparison: Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Analyzing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Financial Comparison

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) Critical Analysis

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Reviewing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Analyzing Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Critical Survey: Anbio Biotechnology (NASDAQ:NNNN) versus Oncocyte (NASDAQ:IMDX)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Reviewing Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Head-To-Head Review

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Financial Contrast

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

defenseworld.net

Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN)

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) a

defenseworld.net

Head to Head Comparison: Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX)

Oncocyte (NASDAQ: IMDX - Get Free Report) and Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) a

benzinga.com

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

benzinga.com

Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%

Trump's second term is fueling an IPO comeback, with 2025 listings up 50% and five stocks alread

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday

benzinga.com

Dow Jumps Over 200 Points; ISM Services PMI Falls In September

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday

benzinga.com

H.B. Fuller Posts Better-Than-Expected Earnings, Joins AeroVironment, MillerKnoll And Other Big Stoc

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com

AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com

Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On T